Sorrento's unit Scilex inks distribution deal for pain drug ZTlido with CH Trading

Aug. 17, 2022 9:31 AM ETSorrento Therapeutics, Inc. (SRNE), SCLXBy: Ravikash, SA News Editor

Business agreement


  • Sorrento's (NASDAQ:SRNE) unit Scilex Holding signed a distribution agreement for its non-opioid pain drug ZTlido with CH Trading Group, for certain territories including Middle East and North Africa.
  • "We are pleased to work with CH Trading to help support us through the processes of obtaining global Halal certification as well as regulatory approval in the overseas designated territories," said Scilex CEO Jaisim Shah.
  • Scilex is currently in the middle of a merger with SPAC Vickers Vantage I (NASDAQ:VCKA) and will go public on Nasdaq under the symbol SCLX.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.